Q Sue Huang, Nikki Turner, Tim Wood, Andrew Anglemyer, Peter McIntyre, Nayyereh Aminisani, Tony Dowell, Adrian Trenholme, Cass Byrnes, Michelle Balm, Christine McIntosh, Sarah Jefferies, Cameron C Grant, Annette Nesdale, Hazel C Dobinson, Priscilla Campbell-Stokes, Karen Daniells, Jemma Geoghegan, Joep de Ligt, Lauren Jelley, Ruth Seeds, Tineke Jennings, Megan Rensburg, Jort Cueto, Ernest Caballero, Joshma John, Emmanuel Penghulan, Chor Ee Tan, Xiaoyun Ren, Klarysse Berquist, Meaghan O'Neill, Maritza Marull, Chang Yu, Andrea McNeill, Tomasz Kiedrzynski, Sally Roberts, Colin McArthur, Alicia Stanley, Susan Taylor, Conroy Wong, Shirley Lawrence, Michael G Baker, Amanda Kvalsvig, Koen Van Der Werff, Gary McAuliffe, Hanna Antoszewska, Meik Dilcher, Jennifer Fahey, Anja Werno, Juliet Elvy, Jenny Grant, Michael Addidle, Nicolas Zacchi, Chris Mansell, Marc-Alain Widdowson, Paul G Thomas, Richard J Webby
BACKGROUND: New Zealand's (NZ) complete absence of community transmission of influenza and respiratory syncytial virus (RSV) after May 2020, likely due to COVID-19 elimination measures, provided a rare opportunity to assess the impact of border restrictions on common respiratory viral infections over the ensuing 2 years. METHODS: We collected the data from multiple surveillance systems, including hospital-based severe acute respiratory infection surveillance, SHIVERS-II, -III and -IV community cohorts for acute respiratory infection (ARI) surveillance, HealthStat sentinel general practice (GP) based influenza-like illness surveillance and SHIVERS-V sentinel GP-based ARI surveillance, SHIVERS-V traveller ARI surveillance and laboratory-based surveillance...
February 2024: Influenza and Other Respiratory Viruses